Inventors list |
Agents list |
Assignees list |
List by place |
Classification tree browser |
Top 100 Inventors |
Top 100 Agents |
Top 100 Assignees |
COMMACK, NY US
1. 20110046232 Orally Dissolving Formulations of Memantine 02-24-20112. 20110046134 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE 02-24-2011
3. 20110028722 NOVEL SOLVATE AND CRYSTALLINE FORMS OF CARBAMOYL-CYCLOHEXANE DERIVATIVES 02-03-2011
4. 20110015208 PHARMACEUTICAL COMPOSITIONS CONTAINING DOPAMINE RECEPTOR LIGANDS AND METHODS OF TREATMENT USING DOPAMINE RECEPTOR LIGANDS 01-20-2011
5. 20100286260 MILNACIPRAN FORMULATIONS - formulations comprising milnacipran or pharmaceutically acceptable salts thereof 11-11-2010
6. 20100280067 INHIBITORS OF ACETYL-COA CARBOXYLASE - compounds that act as acetyl-CoA carboxylase inhibitors 11-04-2010
7. 20100240611 METHODS FOR PREPARING DPP-IV INHIBITOR COMPOUNDS 09-23-2010
8. 20100216745 NOVEL CEPHEM COMPOUNDS USEFUL FOR THE TREATMENT OF BACTERIAL INFECTIONS 08-26-2010
9. 20100197797 METHODS OF MANAGING FIBROMYALGIA USING MILNACIPRAN 08-05-2010
10. 20100197650 COMPOSITIONS AND METHODS OF TREATMENT COMPRISING CEFTAROLINE 08-05-2010
11. 20100168080 NOVEL COMPOUNDS USEFUL AS CC CHEMOKINE RECEPTOR LIGANDS 07-01-2010
12. 20100160323 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE 06-24-2010
13. 20100152160 NOVEL BENZODIOXANE AND BENZOXAZINE DERIVATIVES USEFUL AS CC CHEMOKINE RECEPTOR LIGANDS 06-17-2010
14. 20100125056 CRYSTALLINE FORM OF LINACLOTIDE - crystalline forms of linaclotide as well as to various methods and processes for the preparation and use of the 05-20-2010
15. 20100081723 Memantine For The Treatment Of Childhood Behavioral Disorders 04-01-2010
16. 20100048726 Memantine For The Treatment Of Mild And Mild To Moderate Alzheimer's Disease 02-25-2010
17. 20100048630 METHODS FOR TREATING CNS DISORDERS - methods for treating central nervous system disorders such as Alzheimer's disease 02-25-2010
18. 20100048629 METHODS FOR TREATING NEUROPATHIC PAIN - methods of treating diabetic neuropathic pain comprising administering piperidine derivatives 02-25-2010
19. 20100016334 PHARMACEUTICAL FORMULATIONS CONTAINING DOPAMINE RECEPTOR LIGANDS 01-21-2010
20. 20100010044 NOVEL CRYSTALLINE FORM OF 2-[4-(4-FLUORO-BENZYL)-PIPERIDINE-1-YL]-2-OXO-N-(2-OXO-2,3-DIHYDRO-BENZOX- AZOL-6-YL)-ACETAMIDE 01-14-2010